News

Recent positive interim results of Sanofi’s mRNA-based COVID-19 vaccine candidate Phase 1/2 study confirm the company’s platform robust capabilities and strategy in mRNA. Taking into account public health needs and given sufficient mRNA COVID-19 vaccines supply can be expected going...

Syndax Pharmaceuticals, Inc. and Incyte announced that they have entered into an exclusive worldwide collaboration and license agreement to develop and commercialize axatilimab, Syndax’s anti-CSF-1R monoclonal antibody. “This partnership has the potential to significantly expand and maximize the axatilimab program...

Union therapeutics has signed a strategic partnership and license agreement with Innovent Biologics to develop and commercialise its therapy, orismilast, in China. A potent and selective next-generation PDE4 inhibitor for inflammatory dermatology conditions, orismilast possesses extensive anti-inflammatory properties. Developed originally by...

Paradigm4, an integrated scientific data analytics company, has launched flexFS TM , its innovative, elastic cloud file system for flexible and more resource efficient data storage and scalable computing. flexFS increases data agility and reduces the costs of working with...

Peli BioThermal, the global name in temperature controlled packaging solutions, announces the launch of its newly designed website. Located at www.pelibiothermal.com, the new site offers a wide variety of resources to support the worldwide business of its life sciences...

Union Fisheries, Animal Husbandry, and Dairying Minister, Mr. Parshottam Rupala lauded the efforts of Indian Immunologicals Limited (IIL) for their ability to roll out Covid-19 vaccine drug substance in record time. Indian Immunologicals Ltd (IIL) has quickly responded to the...

Brooks Automation, Inc. announces Brooks Life Sciences Services and Products businesses will be rebranded under the creation of a new identity – Azenta Life Sciences. Azenta will bring together our existing portfolio of life sciences products and services to...